Retrospective Study on Elimination Delay of Methotrexate in High-dose Therapy of Childhood Acute Lymphoblastic Leukemia in China-Reference-Cited by-同舟云学术

Retrospective Study on Elimination Delay of Methotrexate in High-dose Therapy of Childhood Acute Lymphoblastic Leukemia in China

Published:2007-10 Issue:10 Volume:29 Page:688-693
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Xu Weiqun,Tang Yongmin,Song Hua,Shi Shuwen,Yang Shilong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference20 articles.

1. Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172);Hill;Br J Haematol,2004

2. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?;Sterba;Neoplasma,2005

3. CNS-directed therapy for childhood acute lymphoblastic leukemia: childhood all collaborative group overview of 43 randomized trials;Clarke;J Clin Oncol,2003

4. On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemia;Seidel;Leuk Res,1997

5. Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia;Borsi;Cancer Chemother Pharmacol,1987

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies;Cancer Chemotherapy and Pharmacology;2024-06-21

2. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies;2024-02-28

3. Effects of SLCO1B1 on elimination and toxicities of high-dose methotrexate in pediatric acute lymphoblastic leukemia;Pharmacogenomics;2022-10

4. High-dose methotrexate-related pneumonitis in a child with acute lymphoblastic leukemia;Journal of Oncology Pharmacy Practice;2022-07-19

5. Is hypoalbuminemia a risk factor for high-dose methotrexate toxicity in children with acute lymphoblastic leukemia?;Journal of the Egyptian National Cancer Institute;2022-04-18